127 related articles for article (PubMed ID: 11115561)
1. Follicular thyroid cancer cells: a model of metastatic tumor in vitro (review).
Hoelting T; Goretzki PE; Duh QY
Oncol Rep; 2001; 8(1):3-8. PubMed ID: 11115561
[TBL] [Abstract][Full Text] [Related]
2. [Growth and invasion in differentiated thyroid carcinoma. Function of different growth factors].
Hölting T; Duh OY; Clark OH; Herfarth C
Chirurg; 1994 Dec; 65(12):1100-6. PubMed ID: 7851142
[TBL] [Abstract][Full Text] [Related]
3. [Transfection of follicular thyroid gland carcinoma cells with human TSH receptor changes growth, invasion and adhesion].
Hoelting T; Duh QY; Clark OH; Herfarth C
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):281-4. PubMed ID: 14518260
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor enhances proliferation, migration, and invasion of follicular and papillary thyroid cancer in vitro and in vivo.
Hoelting T; Siperstein AE; Clark OH; Duh QY
J Clin Endocrinol Metab; 1994 Aug; 79(2):401-8. PubMed ID: 8045955
[TBL] [Abstract][Full Text] [Related]
5. Pleiotropic effects of thyroid stimulating hormone in a differentiated thyroid cancer cell line. Studies on proliferation, thyroglobulin secretion, adhesion, migration and invasion.
Zielke A; Hoffmann S; Plaul U; Duh QY; Clark OH; Rothmund M
Exp Clin Endocrinol Diabetes; 1999; 107(6):361-9. PubMed ID: 10543413
[TBL] [Abstract][Full Text] [Related]
6. Aberrations of growth factor control in metastatic follicular thyroid cancer in vitro.
Hoelting T; Zielke A; Siperstein AE; Clark OH; Duh QY
Clin Exp Metastasis; 1994 Jul; 12(4):315-23. PubMed ID: 8039305
[TBL] [Abstract][Full Text] [Related]
7. Expression and secretion of endostatin in thyroid cancer.
Hoffmann S; Wunderlich A; Lingelbach S; Musholt PB; Musholt TJ; von Wasielewski R; Zielke A
Ann Surg Oncol; 2008 Dec; 15(12):3601-8. PubMed ID: 18818971
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta 1 is a negative regulator for differentiated thyroid cancer: studies of growth, migration, invasion, and adhesion of cultured follicular and papillary thyroid cancer cell lines.
Hölting T; Zielke A; Siperstein AE; Clark OH; Duh QY
J Clin Endocrinol Metab; 1994 Sep; 79(3):806-13. PubMed ID: 8077365
[TBL] [Abstract][Full Text] [Related]
9. The regulation of proliferation and invasion in differentiated thyroid cancer by growth factors.
Hoelting T; Duh QY; Clark OH; Herfarth C
Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():29-31. PubMed ID: 8980996
[TBL] [Abstract][Full Text] [Related]
10. Thyrotropin stimulates invasion and growth of follicular thyroid cancer cells via PKC- rather than PKA-activation.
Hoelting T; Tezelman S; Siperstein AE; Duh QY; Clark OH
Biochem Biophys Res Commun; 1993 Sep; 195(3):1230-6. PubMed ID: 8216254
[TBL] [Abstract][Full Text] [Related]
11. Biphasic effects of thyrotropin on invasion and growth of papillary and follicular thyroid cancer in vitro.
Hoelting T; Tezelman S; Siperstein AE; Duh QY; Clark OH
Thyroid; 1995 Feb; 5(1):35-40. PubMed ID: 7787431
[TBL] [Abstract][Full Text] [Related]
12. Early tumor growth in metastatic organs influenced by the microenvironment is an important factor which provides organ specificity of colon cancer metastasis.
Hara Y; Ogata Y; Shirouzu K
J Exp Clin Cancer Res; 2000 Dec; 19(4):497-504. PubMed ID: 11277329
[TBL] [Abstract][Full Text] [Related]
13. Translocation (10;14)(q24;q32) as the sole chromosomal abnormality in a metastatic follicular thyroid carcinoma.
Horton ES; Malone VS; Dobin SM; Donner LR
Cancer Genet Cytogenet; 2009 Apr; 190(1):43-5. PubMed ID: 19264233
[No Abstract] [Full Text] [Related]
14. Inhibition of transforming growth factor beta signaling reduces pancreatic adenocarcinoma growth and invasiveness.
Gaspar NJ; Li L; Kapoun AM; Medicherla S; Reddy M; Li G; O'Young G; Quon D; Henson M; Damm DL; Muiru GT; Murphy A; Higgins LS; Chakravarty S; Wong DH
Mol Pharmacol; 2007 Jul; 72(1):152-61. PubMed ID: 17400764
[TBL] [Abstract][Full Text] [Related]
15. Retinoic acid inhibits angiogenesis and tumor growth of thyroid cancer cells.
Hoffmann S; Rockenstein A; Ramaswamy A; Celik I; Wunderlich A; Lingelbach S; Hofbauer LC; Zielke A
Mol Cell Endocrinol; 2007 Jan; 264(1-2):74-81. PubMed ID: 17101211
[TBL] [Abstract][Full Text] [Related]
16. Metastatic dissemination of human malignant oral keratinocyte cell lines following orthotopic transplantation reflects response to TGF-beta 1.
Prime SS; Eveson JW; Stone AM; Huntley SP; Davies M; Paterson IC; Robinson CM
J Pathol; 2004 Aug; 203(4):927-32. PubMed ID: 15258995
[TBL] [Abstract][Full Text] [Related]
17. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
[TBL] [Abstract][Full Text] [Related]
18. Thyroid targeting of the N-ras(Gln61Lys) oncogene in transgenic mice results in follicular tumors that progress to poorly differentiated carcinomas.
Vitagliano D; Portella G; Troncone G; Francione A; Rossi C; Bruno A; Giorgini A; Coluzzi S; Nappi TC; Rothstein JL; Pasquinelli R; Chiappetta G; Terracciano D; Macchia V; Melillo RM; Fusco A; Santoro M
Oncogene; 2006 Aug; 25(39):5467-74. PubMed ID: 16785999
[TBL] [Abstract][Full Text] [Related]
19. Rat myoblastic sarcoma cell lines. A model for the study of invasion, metastasis, and myogenic differentiation.
Babaï F; Royal A
Lab Invest; 1994 Jun; 70(6):907-15. PubMed ID: 8015294
[TBL] [Abstract][Full Text] [Related]
20. [Establishment of human ovarian carcinoma cell lines with directional highly lymphatic metastasis and study of their biological characteristics].
Ruan HY; Li DR; Li L; Guan X; Zhang W
Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):482-6. PubMed ID: 17961340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
